A. Clayton, S. Kingsberg, J. Simon
May 1, 2018
Citations
0
Influential Citations
4
Citations
Journal
Obstetrics & Gynecology
Abstract
INTRODUCTION:Bremelanotide, an investigational new drug, is a melanocortin 4 receptor agonist that has demonstrated efficacy in treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. The objective of this analysis was to evaluate sustained maintenance of bremelanotide effect o